MARATTO

article

Dataset for the Development of AI-Powered Diagnostic Models for Vector-Borne Diseases: a perspective from Burkina Faso

Abstract

Vector-borne diseases, such as malaria, dengue, and yellow fever, pose a major public health challenge, particularly in the Hauts-Bassins region of Burkina Faso, where access to healthcare services is often limited. This dataset provides a structured collection of clinical and demographic data from 300 patients in the Dafra and Do health districts, collected over a five-week period. It is carefully annotated with patient symptoms, medical history, and laboratory-confirmed diagnoses, offering a valuable source for symptom analysis and identification of epidemiological trends. The analysis of patient records revealed that malaria was the most prevalent disease, accounting for 73.57% of cases. The majority of patients were female, representing $\mathbf{5 1. 0 2 \%}$ of the sample. Additionally, an imbalance ratio of 22.5 highlights a significant disparity in class distribution, which may lead to a biased model favoring the majority class. Furthermore, 20 symptoms were observed in at least 20% of the patients. By making this dataset available, we aim to facilitate the development of artificial intelligence models for the automatic diagnosis of vector-borne diseases. In addition, this data set serves as a valuable resource for local public health initiatives, allowing scalable disease surveillance and improving diagnostic accuracy in underserved areas.

Research topics

  • Digital Imaging for Blood Diseases
  • COVID-19 diagnosis using AI
  • Artificial Intelligence in Healthcare

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1109/inc465408.2025.11256479

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.